Correlation Between Dynapack International and Medigen Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dynapack International and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynapack International and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynapack International Technology and Medigen Biotechnology, you can compare the effects of market volatilities on Dynapack International and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynapack International with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynapack International and Medigen Biotechnology.

Diversification Opportunities for Dynapack International and Medigen Biotechnology

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Dynapack and Medigen is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Dynapack International Technol and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and Dynapack International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynapack International Technology are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of Dynapack International i.e., Dynapack International and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between Dynapack International and Medigen Biotechnology

Assuming the 90 days trading horizon Dynapack International Technology is expected to generate 1.76 times more return on investment than Medigen Biotechnology. However, Dynapack International is 1.76 times more volatile than Medigen Biotechnology. It trades about 0.35 of its potential returns per unit of risk. Medigen Biotechnology is currently generating about -0.07 per unit of risk. If you would invest  10,200  in Dynapack International Technology on September 2, 2024 and sell it today you would earn a total of  9,600  from holding Dynapack International Technology or generate 94.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dynapack International Technol  vs.  Medigen Biotechnology

 Performance 
       Timeline  
Dynapack International 

Risk-Adjusted Performance

27 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Dynapack International Technology are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Dynapack International showed solid returns over the last few months and may actually be approaching a breakup point.
Medigen Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Dynapack International and Medigen Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dynapack International and Medigen Biotechnology

The main advantage of trading using opposite Dynapack International and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynapack International position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.
The idea behind Dynapack International Technology and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk